Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma.
Justin M LebenthalJunting ZhengPaul A GlareEileen M O'ReillyAndrew C YangAndrew S EpsteinPublished in: Cancer (2021)
The Memorial Sloan Kettering Prognostic Score (MPS) is a new scoring system that incorporates markers of inflammation found in individuals' blood at the diagnosis of metastatic pancreatic cancer. Data suggest that the MPS may help to determine prognosis.